(14557385), N. T., (4246147), M. M., (15263530), V. I., (14557379), S. M., (14442135), S. H., (15263533), K. M., . . . (79420), S. D. (2023). Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: Potential for combined chemoimmunotherapy.
Chicago Style (17th ed.) Citation(14557385), Nassiba Taib, et al. Treatment with Decitabine Induces the Expression of Stemness Markers, PD-L1 and NY-ESO-1 in Colorectal Cancer: Potential for Combined Chemoimmunotherapy. 2023.
MLA (9th ed.) Citation(14557385), Nassiba Taib, et al. Treatment with Decitabine Induces the Expression of Stemness Markers, PD-L1 and NY-ESO-1 in Colorectal Cancer: Potential for Combined Chemoimmunotherapy. 2023.
Warning: These citations may not always be 100% accurate.